VIDEO | 00:43
Caroline Gleason starts her day with coffee. She says her research is focused on a group of cancer drugs called CDK4/6 inhibitors and how they work, especially in patients with liposarcoma. She enrolled in GSK because she wanted a translational program in an interesting and exciting city.